Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

Completed · Phase 1

Conditions studied: Obesity, Weight Gain, Psychotropic Induced Weight Gain

In brief

Recent but limited short term studies have shown that Metformin can slow down weight gain in obese children and in children with psychotropic-induced weight gain, two distinct pediatric populations that are at risk for obesity related co-morbid conditions. The purpose of this study is to conduct a long term prospective pilot cohort study to investigate the use of Metformin to prevent or decrease weight gain in two cohorts of children: 1) children with psychotropic induced weight gain on Metformin and 2) children with BMI above the 95th percentile on Metformin. Both study populations will be enrolled in a lifestyle weight management program

Key facts

Study ID
NCT01231074
Run by
Nationwide Children's Hospital
People needed
96
Starts
2010-02-01
Expected to finish
2013-05-01
Last updated by the study team
2019-01-02

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.